Margo Warren to share Foundation’s insights at Indo-Pacific Regulatory Strengthening Program (RSP) Forum and Partners' Meeting

The sixth Steering Committee Meeting, Forum and Partners’ Meeting of Australia’s Indo-Pacific Regulatory Strengthening (RSP) Program will be held in Kuala Lumpur, co-hosted by Malaysia’s National Pharmaceutical Regulatory Agency (NPRA).

In alignment with the global health priorities highlighted during 2026 World Health Day, this year’s meeting will focus on “Building a Healthier World for All.” This theme reinforces the Program’s goals to strengthen regulatory frameworks, improve access to quality-assured medicines and support healthier communities across the region.

Specifically, panels will explore themes on information-exchange pathways, the development of global health products and emerging challenges.

As a speaker on the “Quality Assured Medicines” panel, Margo Warren, Director of Government Engagement & Policy at the Access to Medicine Foundation, will share findings on access and availabililty in small island states, drawing insights from the 2024 Access to Medicine Index and Tackling the diabetes care crisis in the Pacific: Insulin and medicine access, published in 2025.

She will speak alongside representatives from Gilead, GSK, Papua New Guinea’s Ministry of Health and Fiji’s Medicine Regulatory Authority.

About the Indo-Pacific Regulatory Strengthening (RSP) Program

The RSP program – led by Australia’s Therapeutic Goods Administration – incorporates 22 countries from Southeast Asia and the Pacific under the Australian government’s Partnership for a Healthy Region Initiative. The RSP Steering Committee Meeting, Forum and Partners’ Meeting bring together participants from the participating regulatory agencies and partners with aligned goals, such as the World Health Organization. Since 2018, representatives have convened to discuss strategic and operational aspects of Program delivery and to identify emerging challenges and priorities.